(Q41185198)

28 September 2017

1 reference

title

Dyskinesias and their treatment with essential fatty acids: a review (English)

1 reference

28 September 2017

0 references

1 reference

Vaddadi K

1

1 reference

28 September 2017

1 August 1996

1 reference

Prostaglandins, Leukotrienes and Essential Fatty Acids

28 September 2017

1 reference

28 September 2017

55

1 reference

28 September 2017

1-2

1 reference

28 September 2017

89-94

1 reference

Direct regulation of ion channels by fatty acids

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Effects of estrogen on the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Fatty acids and steroid hormone action

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Excitotoxic injury of the neostriatum: a model for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Effect of ADP on PGE1Formation in Blood Platelets from Patients with Depression, Mania and Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Schizophrenia as a prostaglandin deficiency disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Platelet and erythrocyte membrane lipid and phospholipid patterns in different types of mental patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Penicillin and essential fatty acid supplementation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Alpha-tocopherol in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Investigations into the nature of the peri-oral movements induced by 2-(N,N-dipropyl)amino-5,6-dihydroxytetralin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Essential fatty acids in plasma phospholipids in schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Factors associated with slow progression in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Preface--fatty acids and cell signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Potentiation of NMDA receptor currents by arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-3278%2896%2990151-9

7 January 2021

10.1016/S0952-3278(96)90151-9

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

8888129